Sprites
Donnerstag, 23.05.2013Börsentäglich über 11.000 News von 441 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

TRANSGENE

WKN: 913048  ISIN: FR0005175080  Ticker-Symbol: TGNA 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TRANSGENE Chart 1 Jahr
1-Woche-Intraday-Chart
TRANSGENE 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
9,305
9,446
08:43
Aktuelle News zur TRANSGENE Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
21.05.52
Regulatory News Transgene SA (Paris:TNG) (Euronext Paris: TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer...
Mehr lesen zu:
Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
21.05.38
The Start-up Company Will Develop Therapeutic Antibodies against Novel Targets in the Fields of Cancer and Inflammation Regulatory News: Transgene SA (Euronext Paris: TNG)(Paris:TNG)...
Mehr lesen zu:
Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives
17.05.56
The Start-up Company Will Develop Therapeutic Antibodies against Novel Targets in the Fields of Cancer and Inflammation Regulatory News: Transgene SA (Euronext Paris: TNG)(Paris:TNG)...
Mehr lesen zu:
Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives
17.05.77
ElsaLys Biotech, ein Spinoff-Unternehmen von Transgene R&D, wird neuartige monoklonale Antikörper gegen klassenerste Angriffsziele für die Behandlung von Krebs und Entzündungskrankheiten...
Mehr lesen zu:
ElsaLys Biotech, ein neuer Startup-Akteur in der Arena therapeutischer monoklonaler Antikörper, meldet erste Finanzierungsrunde mit Transgene und Sofimac
17.05.63
Spin-off from Transgene R&D, ElsaLys Biotech will develop novel monoclonal antibodies against first-in-class targets for the treatment of cancer inflammatory diseases. Dr Jean-Yves Bonnefoy...
Mehr lesen zu:
The start-up ElsaLys Biotech, a new player in the therapeutic monoclonal antibody arena, announces the first round of financing with Transgene and Sofimac Partners
15.05.45
Regulatory News Transgene SA (Paris:TNG) (Euronext Paris: TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer...
Mehr lesen zu:
Transgene Announces that Clinical Data with Pexa-Vec will be Presented at the 2013 American Society of Clinical Oncology Annual Meeting
29.04.39
Regulatory News: Transgene SA (Paris:TNG) (Euronext Paris: FR0005175080), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs...
Mehr lesen zu:
Transgene: Promising Final Data from the Phase 2 HCVac Trial of TG4040 Presented at EASL 2013
29.04.45
Initiation of a Phase I study in 2014 New first in class immunotherapeutic to treat CHB Regulatory News: Transgene SA (Paris:TNG) (Euronext Paris: FR0005175080), a ...
Mehr lesen zu:
Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013
22.04.26
Regulatory News Transgene (Paris:TNG) (Euronext Paris: FR0005175080) today issues its quarterly financial report as of March 31, 2013 (first quarter of 2013). Revenue: ...
Mehr lesen zu:
Transgene : First Quarter 2013 Financial Report
08.04.45
Regulatory News: Transgene SA (Paris:TNG) (Euronext Paris: FR0005175080), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs...
Mehr lesen zu:
Transgene to Present New Data on TG1050 and TG4040 to Treat Chronic Hepatitis B and C at EASL 2013
28.03.7
26.03.8
25.03.-
25.03.3
25.03.3
25.03.78
PARIS (dpa-AFX) - Sanofi (SNY) and Transgene SA announced a collaboration agreement for the creation of an industrial platform for the production of immunotherapy products including Transgene's...
Mehr lesen zu:
Sanofi, Transgene Announce Agreement For Creation Of Industrial Platform
25.03.100
- Creation of a new state-of-the-art industrial platform at Genzyme's unit in Lyon - Regulatory News: Sanofi (EURONEXT: SAN and NYSE: SNY) and Transgene SA (Paris:TNG) (NYSE-Euronext:...
Mehr lesen zu:
Sanofi and Transgene Announce Innovative Long-Term Collaboration for the Production of Immunotherapy Treatments
21.03.44
Solid operational performance in 2012, in preparation of key milestones in 2013 with the possible start of two phase 3 clinical trials for our most advanced products Cash...
Mehr lesen zu:
Transgene: Annual Results 2012 and Business Update
01.03.27
Regulatory News: Transgene S.A. (Paris:TNG)(Euronext Paris:FR0005175080) today announced that Philippe Archinard, Chairman & Chief Executive Officer, will...
Mehr lesen zu:
Transgene to Present at the Cowen & Company 33rd Annual Healthcare Conference
18.02.1
Seite: 1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
Aufklappen
Schliessen